The development of CRC is a multistep process which accumulates different gene mutations, chromosomal abnormalities and epigenetic changes.9,10 The mutations within KRAS proto-oncogen, predominately within codons 12 and 13, activate RAS/RAF signalling and are thought to occur early in carcinogenesis of CRC. The gene discussed is KRAS; the disease is colorectal carcinoma.